Top compounds associated with response to ANKRD62


Feature Type Standardized
Nominal ANOVA
mRNA ML006 CTRPv2 pan-cancer AAC -0.028 0.4
mRNA quizartinib CTRPv2 pan-cancer AAC -0.028 0.4
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.026 0.4
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.4
mRNA fingolimod CTRPv2 pan-cancer AAC -0.027 0.4
mRNA lovastatin CTRPv2 pan-cancer AAC -0.028 0.4
mRNA CHM-1 CTRPv2 pan-cancer AAC 0.024 0.4
mRNA PF-4800567 hydrochloride CTRPv2 pan-cancer AAC 0.041 0.5
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.026 0.5
mRNA BRD-K48334597 CTRPv2 pan-cancer AAC -0.052 0.5
Download CSV